Skip to main content
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.715
+0.015 (0.88%)
Aug 14, 2025, 2:04 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Therapeutics
16.18M
Log In
Log In
Log In
Log In
Upgrade
Therapeutics Growth
-42.66%
Log In
Log In
Log In
Log In
Upgrade
Contract Research
2.54M
Log In
Log In
Log In
Log In
Upgrade
Contract Research Growth
-16.28%
Log In
Log In
Log In
Log In
Upgrade
Corporate and Other
-
Log In
Log In
Log In
Log In
Upgrade
Corporate and Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
18.72M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-40.09%
Log In
Log In
Log In
Log In
Upgrade